Skip to main content

Krensavage Asset Management, LLC

Position in ENTA — Enanta Pharmaceuticals Inc

CIK 1609251 NEW YORK, NY

Position in ENTA

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$36,199,322
-$7,426,648 QoQ
Shares Held
2,866,138
+3.6% QoQ
Ownership
9.86%
of shares outstanding
% of Portfolio
14.16%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in ENTA Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

Krensavage Asset Management, LLC holds $143,120,529 across 9 Biotechnology names. ENTA ranks #1 (25.3% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ENTA
Enanta Pharmaceuticals Inc
This page
2,866,138 $36,199,322

All Filings in ENTA

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $36,199,322 2,866,138
2025-12-31 $43,625,970 2,766,390
2025-09-30 $25,309,894 2,114,444
2025-06-30 $15,985,196 2,114,444
2025-03-31 $11,683,554 2,116,586
2024-12-31 $12,174,992 2,117,390
2024-09-30 $15,520,046 1,498,074
2024-06-30 $16,229,853 1,251,338
2024-03-31 $19,635,271 1,124,586
2023-12-31 $6,989,973 742,824
2023-09-30 $8,211,100 735,103
2023-06-30 $14,714,918 687,613
2023-03-31 $24,397,492 603,301
2022-12-31 $27,670,933 594,818
2022-09-30 $30,570,103 589,360
2022-06-30 $29,532,783 624,768
2022-03-31 $39,065,577 548,828
2021-12-31 $42,183,547 564,102
2021-09-30 $53,218,301 936,777
2021-06-30 $41,353,996 939,650
2021-03-31 $42,555,663 862,848
2020-12-31 $36,155,943 858,811
2020-09-30 $37,783,561 825,329
2020-06-30 $38,315,401 763,103
2020-03-31 $36,017,354 700,318